|
Oct 3
|
CALQUENCE® (acalabrutinib) granted Priority Review in the US for patients with untreated mantle cell lymphoma
|
|
Oct 3
|
Owkin and AstraZeneca to develop AI tool for breast cancer testing
|
|
Oct 3
|
Arcus and AstraZeneca enter trial collaboration for renal cancer treatment
|
|
Oct 3
|
3 UK Stocks Estimated To Be Trading Below Their Intrinsic Value
|
|
Oct 1
|
AstraZeneca's Enhertu sBLA Gets FDA Priority Tag for Expanded Use
|
|
Oct 1
|
ENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Priority Review in the US for patients with HER2-low or HER2-ultralow metastatic breast cancer who have received at least one line of endocrine therapy
|
|
Oct 1
|
5 FDA decisions to watch in the fourth quarter
|
|
Sep 30
|
AstraZeneca (AZN): A Strong Buy as FDA Approves Key Cancer Treatments and Revenue Surges
|
|
Sep 30
|
Is AstraZeneca PLC (NASDAQ:AZN) The Top Global Stock To Buy Now?
|
|
Sep 29
|
Is AstraZeneca PLC (AZN) the Best Cheap Growth Stock to Buy According to Analysts?
|
|
Sep 28
|
15 Unhealthiest Countries in Europe
|
|
Sep 27
|
Pharma Stock Roundup: JNJ's 3rd Talc-Related Bankruptcy Filing & More
|
|
Sep 27
|
The Zacks Analyst Blog Highlights Toyota Motor, AstraZeneca, Chubb, Air T and Preformed Line Products
|
|
Sep 27
|
US’ first self-administered flu vaccine could increase accessibility and uptake
|
|
Sep 27
|
ANGLE PLC (ANPCY) (Q2 2024) Earnings Call Transcript Highlights: Key Takeaways from the ...
|
|
Sep 27
|
AstraZeneca’s Tagrisso gains FDA approval for stage III NSCLC
|
|
Sep 26
|
Top Stock Reports for Toyota, AstraZeneca & Chubb
|
|
Sep 26
|
AstraZeneca Stock Up Almost 14% in 6 Months: Time to Buy?
|
|
Sep 26
|
AZN's Tagrisso Gets FDA Nod for Expanded Use in NSCLC
|
|
Sep 26
|
AstraZeneca's Top-Selling Cancer Drug Tagrisso Receives FDA Green Light For Another Lung Cancer Indication
|